On this page
Avlayah
tividenofusp alfa-eknm
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Avlayah
Proper name
tividenofusp alfa-eknm
Licence type
351(a)
BLA number
761485
Applicant
Denali Therapeutics Inc.
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 150MG | For Injection | Intravenous | Single-Dose Vial | Rx | March 24, 2026 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |